FDA.reportPublic FDA data

Application 084115

Type
ANDA
Sponsor
UPSHER SMITH LABS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CHLORPROMAZINE HYDROCHLORIDECHLORPROMAZINE HYDROCHLORIDETABLET;ORAL200MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0781-5917Chlorpromazine HydrochlorideChlorpromazine HydrochlorideSandoz IncANDACurrent
0781-5917Chlorpromazine HydrochlorideChlorpromazine HydrochlorideSandoz IncANDACurrent
0781-5917Chlorpromazine HydrochlorideChlorpromazine HydrochlorideSandoz IncANDACurrent
0781-5917Chlorpromazine HydrochlorideChlorpromazine HydrochlorideSandoz IncANDACurrent
0781-5917Chlorpromazine HydrochlorideChlorpromazine HydrochlorideSandoz IncANDACurrent
0832-0304Chlorpromazine HydrochlorideChlorpromazine HydrochlorideUpsher-Smith Laboratories, Inc.ANDACurrent
0832-0304Chlorpromazine HydrochlorideChlorpromazine HydrochlorideUpsher-Smith Laboratories, Inc.ANDACurrent
0832-0304Chlorpromazine HydrochlorideChlorpromazine HydrochlorideUpsher-Smith Laboratories, Inc.ANDACurrent
0832-6021Chlorpromazine HydrochlorideChlorpromazine HydrochlorideUpsher-Smith Laboratories, LLCANDACurrent
51079-517Chlorpromazine HydrochlorideChlorpromazine HydrochlorideMylan Institutional Inc.ANDACurrent
51079-517Chlorpromazine HydrochlorideChlorpromazine HydrochlorideMylan Institutional Inc.ANDACurrent
64725-0304Chlorpromazine HydrochlorideChlorpromazine HydrochlorideTYA PharmaceuticalsANDACurrent